Quick Answer
MUSTANG BIO, INC. reported Operating Income Loss of -$2.43 million for the year ending 2025.
- MUSTANG BIO, INC. showed an increase of +85.0% in Operating Income Loss from 2024 to 2025.
- This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), MUSTANG BIO, INC.'s Operating Income Loss has declined by 7.6%.
- Historical annual values: Fiscal year 2025: -$2.43 million | Fiscal year 2024: -$16.25 million | Fiscal year 2023: -$49.26 million | Fiscal year 2022: -$76.16 million | Fiscal year 2021: -$66.72 million | Fiscal year 2020: -$56.81 million | Fiscal year 2019: -$45.89 million | Fiscal year 2018: -$31.22 million | Fiscal year 2017: -$31.79 million | Fiscal year 2016: -$11.36 million | Fiscal year 2015: -$2.26 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: